ArticleBMJ neurology open2025

Efgartigimod following plasma exchange in the treatment of subjects with generalised myasthenia gravis: study protocol for a multicentre, three-arm, open-label study.

Kan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.